These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10900662)

  • 1. [Anti-Alzheimer drugs: ethical aspects of research and practice].
    Berghmans RL
    Tijdschr Gerontol Geriatr; 2000 Jun; 31(3):100-6. PubMed ID: 10900662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ethical aspects of anti-Alzheimer drugs: experiences of caregivers].
    Huizing AR; Berghmans RL; Widdershoven GA; Verhey FR
    Tijdschr Gerontol Geriatr; 2002 Dec; 33(6):246-51. PubMed ID: 12611287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes for clinical trials in mild-to-moderate dementia to evaluate drugs with presumably symptomatic effects.
    Frolich L
    J Nutr Health Aging; 2007; 11(4):357-8. PubMed ID: 17653499
    [No Abstract]   [Full Text] [Related]  

  • 4. Measuring cognitive change in Alzheimer's disease clinical drug trials.
    Harrison JE
    J Nutr Health Aging; 2007; 11(4):327-9. PubMed ID: 17653492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific symptomatic changes following donepezil treatment of Alzheimer's disease: a multi-centre, primary care, open-label study.
    Rockwood K; Black S; Bedard MA; Tran T; Lussier I;
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):312-9. PubMed ID: 17006874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Outpatient treatment of patients suffering from Alzheimer dementia. Two exploratory studies on the characteristics of therapy in medical practice].
    Haupt M; Rosenfeld S; Stoppe G
    MMW Fortschr Med; 2004 Aug; 146 Suppl 2():51-6. PubMed ID: 16739359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do caregivers' experiences correspond with the concerns raised in the literature? Ethical issues relating to anti-dementia drugs.
    Huizing AR; Berghmans RL; Widdershoven GA; Verhey FR
    Int J Geriatr Psychiatry; 2006 Sep; 21(9):869-75. PubMed ID: 16955453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the therapeutic effects in individual patients with Alzheimer disease].
    Richard E; Lemstra AW; Walstra GJ; van Gool WA
    Ned Tijdschr Geneeskd; 2001 Feb; 145(8):340-5. PubMed ID: 11257811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art.
    Fariello RG
    Funct Neurol; 1997; 12(3-4):221-5. PubMed ID: 9218984
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dementing disorders. What benefits do the new anti-dementia drugs have?].
    Ihl R
    MMW Fortschr Med; 2002 May; Suppl 2():24-6, 28-9. PubMed ID: 12070846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galantamine for Alzheimer's disease and mild cognitive impairment.
    Cusi C; Cantisani TA; Celani MG; Incorvaia B; Righetti E; Candelise L;
    Neuroepidemiology; 2007; 28(2):116-7. PubMed ID: 17409773
    [No Abstract]   [Full Text] [Related]  

  • 12. [Variability of efficacy measures in Alzheimer's disease].
    Musicco M; Pettenati C; Caltagirone C
    Ann Ist Super Sanita; 2005; 41(1):87-91. PubMed ID: 16037656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Final IQWiG to Ginkgo biloba].
    Winckler T
    Pharm Unserer Zeit; 2009; 38(5):454-61. PubMed ID: 19711323
    [No Abstract]   [Full Text] [Related]  

  • 14. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive approach of donepezil and psychosocial interventions on cognitive function and quality of life for Alzheimer's disease: the Osaki-Tajiri Project.
    Meguro M; Kasai M; Akanuma K; Ishii H; Yamaguchi S; Meguro K
    Age Ageing; 2008 Jul; 37(4):469-73. PubMed ID: 18515851
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality of life for caregivers of people with Alzheimer's disease.
    Vellone E; Piras G; Talucci C; Cohen MZ
    J Adv Nurs; 2008 Jan; 61(2):222-31. PubMed ID: 18186913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dementia patients caregivers quality of life: the PIXEL study.
    Thomas P; Lalloué F; Preux PM; Hazif-Thomas C; Pariel S; Inscale R; Belmin J; Clément JP
    Int J Geriatr Psychiatry; 2006 Jan; 21(1):50-6. PubMed ID: 16323256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of galantamine on verbal repetition in AD: a secondary analysis of the VISTA trial.
    Wong VS
    Neurology; 2007 Aug; 69(8):809; author reply 809-10. PubMed ID: 17709718
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of galantamine on behavioural and psychological disturbances and caregiver burden in patients with Alzheimer's disease.
    Monsch AU; Giannakopoulos P;
    Curr Med Res Opin; 2004 Jun; 20(6):931-8. PubMed ID: 15200752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Challenging pharmacotherapy in dementia].
    Ihl R
    MMW Fortschr Med; 2009 Mar; 151(13):46-8. PubMed ID: 19504818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.